STOCK TITAN

[144] Zai Lab Ltd SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Zai Lab Ltd (ZLAB) filed a Form 144 reporting a proposed sale of 456 American Depositary Shares (ADS) with an aggregate market value of $15,616.6810/02/2025 through Fidelity Brokerage Services on NASDAQ. The ADS were acquired on 10/01/2025 via restricted stock vesting and were paid as compensation. The filer also disclosed two prior sales in the last three months: 4,096 ADS sold on 08/08/2025 for $139,304.96 and 1,438 ADS sold on 08/15/2025 for $50,931.59. Total shares outstanding reported are 421,725,450. The filing includes the standard representation that the seller is unaware of any undisclosed material adverse information.

Zai Lab Ltd (ZLAB) ha presentato una Form 144 riferendo una vendita proposta di 456 American Depositary Shares (ADS) con un valore di mercato complessivo di $15.616,68 da vendere il 02/10/2025 tramite Fidelity Brokerage Services su NASDAQ. Gli ADS sono stati acquistati il 01/10/2025 tramite vesting di azioni vincolate e sono stati pagati come compensazione. Il depositante ha inoltre comunicato due vendite precedenti negli ultimi tre mesi: 4.096 ADS venduti l'08/08/2025 per $139.304,96 e 1.438 ADS venduti l'15/08/2025 per $50.931,59. Le azioni totali in circolazione riportate sono 421.725.450. Nella dichiarazione si allega la usuale affermazione secondo cui il venditore non è a conoscenza di alcuna informazione materiale avversa non divulgata.

Zai Lab Ltd (ZLAB) presentó un Formulario 144 informando de una venta propuesta de 456 American Depositary Shares (ADS) con un valor de mercado agregado de $15,616.68 a realizarse el 02/10/2025 a través de Fidelity Brokerage Services en NASDAQ. Los ADS fueron adquiridos el 01/10/2025 mediante vesting de acciones restringidas y se pagaron como compensación. El presentador también divulgó dos ventas previas en los últimos tres meses: 4,096 ADS vendidos el 08/08/2025 por $139,304.96 y 1,438 ADS vendidos el 08/15/2025 por $50,931.59. Las acciones totales en circulación reportadas son 421,725,450. El documento incluye la declaración estándar de que el vendedor no tiene conocimiento de ninguna información material adversa no revelada.

Zai Lab Ltd (ZLAB)456 American Depositary Shares (ADS)의 합계 시가가 $15,616.68로 NASDAQ의 Fidelity Brokerage Services를 통해 2025년 10월 2일에 매도할 것을 보고하는 Form 144를 제출했습니다. ADS는 2025년 10월 1일제한된 주식 취득(vesting)을 통해 취득되었으며 보상으로 지급되었습니다. 제출자는 지난 세 달 동안의 두 건의 이전 매도도 공개했습니다: 4,096 ADS2025년 8월 8일에 매도되어 $139,304.96를 얻었고 1,438 ADS2025년 8월 15일에 매도되어 $50,931.59를 얻었습니다. 보고된 총 발행주식 수는 421,725,450주입니다. 제출에는 매도인이 공개되지 않은 중요한 악재 정보가 없다는 표준 진술이 포함되어 있습니다.

Zai Lab Ltd (ZLAB) a déposé un Form 144 déclarant une vente proposée de 456 American Depositary Shares (ADS) avec une valeur marchande globale de 15 616,68 $ à vendre le 02/10/2025 par Fidelity Brokerage Services sur NASDAQ. Les ADS ont été acquis le 01/10/2025 via un vesting d’actions restreintes et ont été payés en tant que rémunération. Le déposant a également divulgué deux ventes antérieures au cours des trois derniers mois : 4 096 ADS vendus le 08/08/2025 pour 139 304,96 $ et 1 438 ADS vendus le 15/08/2025 pour 50 931,59 $. Le nombre total d’actions en circulation rapporté est 421 725 450. Le dossier comprend la déclaration standard selon laquelle le vendeur n’a connaissance d’aucune information défavorable matérielle non divulguée.

Zai Lab Ltd (ZLAB) hat ein Form 144 eingereicht, das einen geplanten Verkauf von 456 American Depositary Shares (ADS) mit einem aggregierten Marktwert von $15.616,68 vorsieht, der am 02.10.2025 über Fidelity Brokerage Services an der NASDAQ verkauft wird. Die ADS wurden am 01.10.2025 durch Vesting von Restricted Stock erworben und als Vergütung bezahlt. Der Antragsteller gab außerdem zwei frühere Verkäufe in den letzten drei Monaten bekannt: 4.096 ADS wurden am 08.08.2025 für $139.304,96 verkauft und 1.438 ADS wurden am 15.08.2025 für $50.931,59 verkauft. Die insgesamt ausgegebenen Aktien belaufen sich auf 421.725.450. Die Einreichung enthält die standardmäßige Erklärung, dass der Verkäufer keine unbekannten wesentlichen nachteiligen Informationen besitzt.

Zai Lab Ltd (ZLAB) قدمت نموذج 144 يوضح بيعاً مقترحاً لـ 456 سهم إيداع أمريكي (ADS) بــ قيمة سوقية إجمالية قدرها 15,616.68 دولار ليُباع في 02/10/2025 عبر Fidelity Brokerage Services في ناسداك. تم الاستحواذ على ADS في 01/10/2025 عبر إحقاق أسهم مقيدة وتم دفعها كتـعويض. كما كشفت المقدم عن بيعين سابقين خلال الثلاثة أشهر الأخيرة: 4,096 ADS بيعت في 08/08/2025 مقابل $139,304.96 و 1,438 ADS بيعت في 15/08/2025 مقابل $50,931.59. الأسهم الإجمالية المطروحة هي 421,725,450. يتضمن الملف البيان القياسي بأن البائع لا يعلم بأي معلومات سلبية مادية لم تُكشف.

Zai Lab Ltd (ZLAB) 提交了 Form 144,报告拟出售 456 只美国存托股 (ADS),其 总市场价值为 $15,616.68,将于 2025-10-02 通过 Fidelity Brokerage Services 在 NASDAQ 出售。ADS 于 2025-10-01 通过 限制性股票归属 获得,并作为 薪酬 支付。申报人还披露了过去三个月内的两笔前次交易:4,096 ADS2025-08-08 出售,成交价为 $139,304.961,438 ADS2025-08-15 出售,成交价为 $50,931.59。报告的总流通股数为 421,725,450 股。文件包含标准声明,卖方并不知道任何未披露的重大不利信息。

Positive
  • Disclosure compliance: Form 144 filed and includes acquisition, sale dates, amounts, and broker information
  • Source of shares disclosed: 456 ADS were acquired via restricted stock vesting and paid as compensation
Negative
  • Insider selling activity: 5,534 ADS sold in the past three months for total gross proceeds of $190,236.55
  • Small transaction relative to shares outstanding: While disclosed, the proposed 456 ADS represent a very small fraction of the 421,725,450 outstanding shares

Insights

TL;DR: Insider plans to sell a small block of ADS after recent vesting; prior open-market sales were disclosed.

The filing shows the sale arises from newly vested restricted ADS reported as compensation on 10/01/2025, with a proposed sale of 456 ADS on 10/02/2025 through Fidelity. The filer also disclosed two open-market sales in August totaling 5,534 ADS and roughly $190,236 in gross proceeds. These disclosures meet Rule 144 notice requirements and provide transparent timing and proceeds for investor review.

Zai Lab Ltd (ZLAB) ha presentato una Form 144 riferendo una vendita proposta di 456 American Depositary Shares (ADS) con un valore di mercato complessivo di $15.616,68 da vendere il 02/10/2025 tramite Fidelity Brokerage Services su NASDAQ. Gli ADS sono stati acquistati il 01/10/2025 tramite vesting di azioni vincolate e sono stati pagati come compensazione. Il depositante ha inoltre comunicato due vendite precedenti negli ultimi tre mesi: 4.096 ADS venduti l'08/08/2025 per $139.304,96 e 1.438 ADS venduti l'15/08/2025 per $50.931,59. Le azioni totali in circolazione riportate sono 421.725.450. Nella dichiarazione si allega la usuale affermazione secondo cui il venditore non è a conoscenza di alcuna informazione materiale avversa non divulgata.

Zai Lab Ltd (ZLAB) presentó un Formulario 144 informando de una venta propuesta de 456 American Depositary Shares (ADS) con un valor de mercado agregado de $15,616.68 a realizarse el 02/10/2025 a través de Fidelity Brokerage Services en NASDAQ. Los ADS fueron adquiridos el 01/10/2025 mediante vesting de acciones restringidas y se pagaron como compensación. El presentador también divulgó dos ventas previas en los últimos tres meses: 4,096 ADS vendidos el 08/08/2025 por $139,304.96 y 1,438 ADS vendidos el 08/15/2025 por $50,931.59. Las acciones totales en circulación reportadas son 421,725,450. El documento incluye la declaración estándar de que el vendedor no tiene conocimiento de ninguna información material adversa no revelada.

Zai Lab Ltd (ZLAB)456 American Depositary Shares (ADS)의 합계 시가가 $15,616.68로 NASDAQ의 Fidelity Brokerage Services를 통해 2025년 10월 2일에 매도할 것을 보고하는 Form 144를 제출했습니다. ADS는 2025년 10월 1일제한된 주식 취득(vesting)을 통해 취득되었으며 보상으로 지급되었습니다. 제출자는 지난 세 달 동안의 두 건의 이전 매도도 공개했습니다: 4,096 ADS2025년 8월 8일에 매도되어 $139,304.96를 얻었고 1,438 ADS2025년 8월 15일에 매도되어 $50,931.59를 얻었습니다. 보고된 총 발행주식 수는 421,725,450주입니다. 제출에는 매도인이 공개되지 않은 중요한 악재 정보가 없다는 표준 진술이 포함되어 있습니다.

Zai Lab Ltd (ZLAB) a déposé un Form 144 déclarant une vente proposée de 456 American Depositary Shares (ADS) avec une valeur marchande globale de 15 616,68 $ à vendre le 02/10/2025 par Fidelity Brokerage Services sur NASDAQ. Les ADS ont été acquis le 01/10/2025 via un vesting d’actions restreintes et ont été payés en tant que rémunération. Le déposant a également divulgué deux ventes antérieures au cours des trois derniers mois : 4 096 ADS vendus le 08/08/2025 pour 139 304,96 $ et 1 438 ADS vendus le 15/08/2025 pour 50 931,59 $. Le nombre total d’actions en circulation rapporté est 421 725 450. Le dossier comprend la déclaration standard selon laquelle le vendeur n’a connaissance d’aucune information défavorable matérielle non divulguée.

Zai Lab Ltd (ZLAB) hat ein Form 144 eingereicht, das einen geplanten Verkauf von 456 American Depositary Shares (ADS) mit einem aggregierten Marktwert von $15.616,68 vorsieht, der am 02.10.2025 über Fidelity Brokerage Services an der NASDAQ verkauft wird. Die ADS wurden am 01.10.2025 durch Vesting von Restricted Stock erworben und als Vergütung bezahlt. Der Antragsteller gab außerdem zwei frühere Verkäufe in den letzten drei Monaten bekannt: 4.096 ADS wurden am 08.08.2025 für $139.304,96 verkauft und 1.438 ADS wurden am 15.08.2025 für $50.931,59 verkauft. Die insgesamt ausgegebenen Aktien belaufen sich auf 421.725.450. Die Einreichung enthält die standardmäßige Erklärung, dass der Verkäufer keine unbekannten wesentlichen nachteiligen Informationen besitzt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What is being proposed for sale in the ZLAB Form 144?

The filer proposes to sell 456 American Depositary Shares on 10/02/2025 through Fidelity Brokerage Services on NASDAQ with an aggregate market value of $15,616.68.

How were the 456 ADS acquired according to the filing?

The 456 ADS were acquired on 10/01/2025 through restricted stock vesting and were received as compensation.

What prior insider sales does the Form 144 disclose for ZLAB?

Two prior sales are disclosed: 4,096 ADS sold on 08/08/2025 for $139,304.96 and 1,438 ADS sold on 08/15/2025 for $50,931.59.

How many Zai Lab shares are outstanding per this filing?

The filing reports 421,725,450 shares outstanding.

Which broker will handle the proposed sale?

The filing lists Fidelity Brokerage Services LLC at the Smithfield, RI address as the broker.
Zai Lab Limited

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Latest SEC Filings

ZLAB Stock Data

3.83B
108.28M
1.74%
42.53%
4.26%
Biotechnology
Pharmaceutical Preparations
Link
China
SHANGHAI